These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 22083261

  • 21. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.
    Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O.
    J Virol; 2004 Sep; 78(18):9798-806. PubMed ID: 15331713
    [Abstract] [Full Text] [Related]

  • 22. NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62.
    Kalveram B, Lihoradova O, Ikegami T.
    J Virol; 2011 Jul; 85(13):6234-43. PubMed ID: 21543505
    [Abstract] [Full Text] [Related]

  • 23. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A, Marcato V, Boissière M, Mansuroglu Z, Tamietti C, Romani M, Simon D, Tian G, Niedergang F, Panthier JJ, Flamand M, Souès S, Bonnefoy E.
    J Virol; 2020 Dec 09; 95(1):. PubMed ID: 33087469
    [Abstract] [Full Text] [Related]

  • 24. The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice.
    Borrego B, Moreno S, de la Losa N, Weber F, Brun A.
    Viruses; 2021 Mar 24; 13(4):. PubMed ID: 33805122
    [Abstract] [Full Text] [Related]

  • 25. Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.
    Ikegami T, Peters CJ, Makino S.
    J Virol; 2005 May 24; 79(9):5606-15. PubMed ID: 15827175
    [Abstract] [Full Text] [Related]

  • 26. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ, Lokugamage N, Nishiyama S, Ikegami T.
    PLoS One; 2017 May 24; 12(9):e0185194. PubMed ID: 28926632
    [Abstract] [Full Text] [Related]

  • 27. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, Spiropoulou CF, Cannon D, Drew CP, Knust B, McElroy AK, Khristova ML, Albariño CG, Nichol ST.
    J Virol; 2011 Dec 24; 85(24):12901-9. PubMed ID: 21976656
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM, Nfon CK, Zhang S, Marszal P, Wilson WC, Morrill JC, Bettinger GE, Peters CJ.
    Vaccine; 2014 Apr 25; 32(20):2345-9. PubMed ID: 24462482
    [Abstract] [Full Text] [Related]

  • 29. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR.
    Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S.
    Ann N Y Acad Sci; 2009 Sep 25; 1171 Suppl 1(Suppl 1):E75-85. PubMed ID: 19751406
    [Abstract] [Full Text] [Related]

  • 30. Development of a novel, single-cycle replicable rift valley Fever vaccine.
    Murakami S, Terasaki K, Ramirez SI, Morrill JC, Makino S.
    PLoS Negl Trop Dis; 2014 Mar 25; 8(3):e2746. PubMed ID: 24651859
    [Abstract] [Full Text] [Related]

  • 31. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K, Juelich TL, Smith JK, Kalveram B, Perez DD, Freiberg AN, Makino S.
    Sci Rep; 2018 Nov 20; 8(1):17097. PubMed ID: 30459418
    [Abstract] [Full Text] [Related]

  • 32. Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH.
    Kainulainen M, Habjan M, Hubel P, Busch L, Lau S, Colinge J, Superti-Furga G, Pichlmair A, Weber F.
    J Virol; 2014 Mar 20; 88(6):3464-73. PubMed ID: 24403578
    [Abstract] [Full Text] [Related]

  • 33. Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.
    Benferhat R, Josse T, Albaud B, Gentien D, Mansuroglu Z, Marcato V, Souès S, Le Bonniec B, Bouloy M, Bonnefoy E.
    J Virol; 2012 Oct 20; 86(20):11333-44. PubMed ID: 22896612
    [Abstract] [Full Text] [Related]

  • 34. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.
    PLoS Negl Trop Dis; 2018 May 20; 12(5):e0006474. PubMed ID: 29742102
    [Abstract] [Full Text] [Related]

  • 35. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.
    Muller R, Saluzzo JF, Lopez N, Dreier T, Turell M, Smith J, Bouloy M.
    Am J Trop Med Hyg; 1995 Oct 20; 53(4):405-11. PubMed ID: 7485695
    [Abstract] [Full Text] [Related]

  • 36. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.
    Vaccine; 2014 Sep 03; 32(39):4901-8. PubMed ID: 25050973
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome.
    Ayers VB, Huang YS, Dunlop JI, Kohl A, Brennan B, Higgs S, Vanlandingham DL.
    Viral Immunol; 2023 Jan 03; 36(1):33-40. PubMed ID: 36399689
    [Abstract] [Full Text] [Related]

  • 38. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T.
    Expert Rev Vaccines; 2017 Jun 03; 16(6):601-611. PubMed ID: 28425834
    [Abstract] [Full Text] [Related]

  • 39. Novel approaches to develop Rift Valley fever vaccines.
    Indran SV, Ikegami T.
    Front Cell Infect Microbiol; 2012 Jun 03; 2():131. PubMed ID: 23112960
    [Abstract] [Full Text] [Related]

  • 40. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
    Boumart Z, Daouam S, Bamouh Z, Jazouli M, Tadlaoui KO, Dungu B, Bettinger G, Watts DM, Elharrak M.
    Vaccine; 2019 Mar 14; 37(12):1642-1650. PubMed ID: 30773401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.